Recent trends in non-viral vector-mediated gene delivery

Area of Science:

• Biotechnology and Nanomedicine
• Gene Therapy Delivery Systems

Background:

• Nucleic acid-based biopharmaceuticals (e.g., plasmid DNA, oligonucleotides, siRNA) offer novel therapeutic potential for intractable diseases.
• Efficient delivery of these nucleic acids into target cells is significantly impeded by biological barriers.
• Nanotechnology has advanced the development of non-viral vectors for intracellular and subcellular gene delivery.

Purpose of the Study:

• To review cellular barriers affecting gene delivery.
• To present the current landscape of non-viral gene vectors for nucleic acid-based nanomedicine.
• To highlight the role of chemical methods in achieving safe and effective transgene expression.

Main Methods:

• Literature review of cellular barriers in gene delivery.
• Overview of non-viral gene vectors including lipoplexes, liposomes, polyplexes, and nanoparticles.
• Discussion of physical and chemical delivery methods for nucleic acids.

Main Results:

• Non-viral vectors, particularly nanoparticles, demonstrate capability in transporting nucleic acids into cells and specific organelles.
• Chemical delivery methods are effective for achieving high-level and safe transgene expression.
• Understanding cellular barriers and uptake mechanisms is crucial for advancing nanotherapy.

Conclusions:

• Nanotechnology-driven non-viral vectors are key to overcoming biological barriers for nucleic acid-based therapies.
• Further research into cellular mechanisms will enhance the development of nucleic acids-based nanotherapy for diverse disorders.
• Optimized non-viral gene delivery systems are essential for realizing the full potential of next-generation biopharmaceuticals.